From February 22, 2024 to March 31, 2024, the company has repurchased 272,900 shares, representing 0.41% for CNY 8.99 million. With this, the company has completed the repurchase of 272,900 shares, representing 0.41% for CNY 8.99 million under the buyback announced on February 23, 2024.
Medprin Regenerative Medical Technologies Co., Ltd.
Equities
301033
CNE100004NB8
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
40.78 CNY | +4.94% |
|
+6.67% | -6.34% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-6.34% | 372M | |
+13.33% | 129B | |
+1.99% | 12.46B | |
-19.52% | 7.02B | |
+52.33% | 6.61B | |
-31.73% | 4.13B | |
+8.95% | 3.46B | |
-17.83% | 2.52B | |
-18.35% | 1.92B | |
-26.90% | 1.62B |
- Stock Market
- Equities
- 301033 Stock
- News Medprin Regenerative Medical Technologies Co., Ltd.
- Tranche Update on Medprin Regenerative Medical Technologies Co., Ltd.'s Equity Buyback Plan announced on February 23, 2024.